Slava Akmaev, Ph.D.

Slava Akmaev, Ph.D., is the Senior Vice President and Chief Analytics Officer at BERG, leading the Analytics division with over 18 years of industry experience. He is responsible for supporting BERG’s drug and diagnostic development programs with data science efforts using BERG’s proprietary artificial intelligence (AI) platform, bAIcis^®. Dr. Akmaev is an advocate for the application of AI tools in digital healthcare and is a frequent speaker at AI industry events. Dr. Akmaev is an inventor on 10+ pending and issued patents and an author on more than 20 peer-reviewed publications, book chapters, and 100+ presentations/ posters.

Prior to his role at BERG, Dr. Akmaev was the Scientific Associate Director at Genzyme Genetics where he launched multiple commercial diagnostic products. While at Genzyme R&D, he led the development of novel statistical approaches for high-throughput “omics” data and performed analytical work in genomics and genetics.

Dr. Akmaev published numerous manuscripts in genomics and was one of the early developers of analytical methodology around high-throughput molecular data. He co-authored the publication of the Long SAGE™ technology, “Using the transcriptome to annotate the genome” in Nature Biotechnology.

Dr. Akmaev holds a Ph.D. in Applied Mathematics from the University of Colorado at Boulder.